Navigation Links
Primrose oil reduces Breast cancer cell growth

Professor Javier Menendez and colleagues from Northwestern University have found supplementation of Oil from evening primrose oil with Herceptin drug found to be effective in reducing the cancer cell growth. // About 30% of breast cancer patients have Her-2/neu receptors (Human Epidermal Growth factor Receptor type 2), which are severe kind of breast cancer that are more aggressive and the activation of the receptors makes the cancer cells to grow and these patients do not respond effectively as negative receptors to chemotherapy and/or anti-estrogen therapy such as tamoxifen.

It is found that the Drug Herceptin is effective in treating patients with Her-2/neu receptors. Researchers have now found that evening primrose oil contains a substance called gamma-linolenic acid (GLA) that acts on Her-2/neu receptors. It is found that GLA acts against the gene that has the DNA coding for the Her-2/neu receptors, unlike Herceptin drug, which blocks the Her-2/neu receptor.

The research team had earlier found that gamma linolenic acid enhanced the action of tamoxifen and chemotherapy drugs against cancer cell. Adding to earlier work the researchers have found that supplementation of GLA along with Herceptin drug augmented the effect of both the drugs and increased the death rate of tumor cells and reduced the growth of cancer cells.

Professor Menendez said, “ Since over-expression of Her-2/neu generally confers resistance to chemotherapy and endocrine therapies, our current findings can explain why GLA increases the efficacy of breast cancer treatments and it has been found that an inexpensive herbal medicine can regulate breast cancer cell growth and help control cancer spread.

Hazel Nunn of Cancer Research UK said, "A lot more work still needs to be done, but gamma-linolenic acid or GLA does seem to be a worthy candidate for further investigation in clinical trials, however, there is no evidence to suggest that taking GLA supplements c
'"/>




Page: 1 2

Related medicine news :

1. Stress reduces your immunity- startling but true!!!!!
2. Thirty minutes of work up per day reduces the risk of Diabetes
3. Aspirin reduces deaths
4. Tomato Sauce reduces Cancer Risk- Study
5. Calcium reduces colon cancer risk
6. New pacemaker reduces risk of heart failure
7. Vitamin D reduces heart risk
8. Back exercises reduces Osteoporosis
9. Caffeine reduces infant blood flow
10. Radiation reduces cancer recurrence
11. Tamoxifen reduces breast cancer risk
Post Your Comments:
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Access Pharmaceuticals Announces Granting of Two US Patents for MuGard 28TM 29 12562 1Access Pharmaceuticals Announces Granting of Two US Patents for MuGard 28TM 29 12562 2Access Pharmaceuticals Announces Granting of Two US Patents for MuGard 28TM 29 12562 3Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 1Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 2Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 3Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 4Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 5Men with Low Testosterone See Multiple Doctors Before Being Diagnosed 3B Many Dissatisfied with Current Treatment Options 48431 6TOPAZ Technologies Introduces Biosafety Software Solution 48428 1TOPAZ Technologies Introduces Biosafety Software Solution 48428 2TOPAZ Technologies Introduces Biosafety Software Solution 48428 3